The Commonwealth Scientific and Industrial Research Organisation is Australia's national science agency and one of the largest and most diverse research agencies in the world.
Australian Biotech Growth Partnerships Learn more>
Australian e-Health Research Centre
Australian Animal Health Laboratory - AAHL plays a key role in protecting public health, animal health, community resilience and trade. Learn more>
Australian Biotech Growth Partnerships - Supports the growth of the biotechnology industry, providing access to CSIRO's capabilities and infrastructure. Learn more>
The Australian e-Health Research Centre - A partnership between CSIRO and the Queensland Government, dedicated to improving health services and clinical treatment for Australians.
Bio21 Collaborative Crystallisation Centre Learn more>
Bio21 Collaborative Crystallisation Centre - Bio21-C3 provides the infrastructure capability to advance biotechnology and medical
research. Learn more>
Analysis at Point of Sampling (APOS) - A hand-held sensor systems for detection and analysis of biochemical and biological materials. Learn more>
Carbon Nanotube Yarn - CSIRO is developing ways to use carbon nanotube components in biomedical devices. Learn more>
Electrospinning creates ultra-fine fibres - Experimental textiles produced by electrospinning are being assessed for medical, industrial and environmental applications. Learn more>
Fluid Dynamics - CSIRO’s biofluid dynamics team develops original medical device technologies to support industries involved in medical devices, diagnostics and treatment. Learn more>
RAFT technologies - CSIRO and DuPont have developed Reversible Addition-Fragmentation chain Transfer (RAFT) for the synthesis of highly specific small‑molecule and biological therapeutics. Learn more>
Working closely with industry partners, CSIRO collaborates on product and technology developments for health and medical related outcomes.
CSIRO draws upon the expertise of chemists, biologists, physicists, engineers and material scientists to address key challenges in health. Our focus is on developing new ‘smart’ technologies which offer platform opportunities where specific parts of the technology can be adapted to many end uses in health and medicine.
This one-day symposium will bring together international and national experts to provide a comprehensive, up-to-date overview of the field of nutrition and genetics that determine the quality of growth and development from conception and throughout early life.
The Preventative Health Flagship is working to improve the health and wellbeing of Australians through research into prevention and early detection of common chronic diseases.
CSIRO has signed a global licensing agreement for its patented RAFT technology. Reversible Addition-Fragmentation chain Transfer (or RAFT) technology is an elegant and powerful polymerisation process that has given rise to a new branch of polymer chemistry.
This Symposium is a satellite meeting of OzBio 2010 and is sponsored by CSIRO, Bruker, Life Technologies and the Australian Society for Biochemistry and Molecular Biology.
Through the Australian e-Health Research Centre, CSIRO invests significantly in using information and communication technologies to improve healthcare and clinical treatment for all Australians.
CSIRO's Diagnosis, Surveillance and Response Group provides a comprehensive diagnostic service for emergency animal diseases, routine quarantine testing, technical advice, education and training.
Our Molecular and Cell Biology capability employs expertise in antibody engineering, the molecular and cellular biology of biomaterials, matrix biology, protein and scaffold display technology, growth factor receptor biology and molecular evolution.
A video showing an interview of the Kolling Institute's Kerrie MacDonald, as she speaks about how the Kolling Institute and CSIRO have discovered genes that differentiate between different types of brain tumours. (0:49)
A CSIRO team - led by Dr Linfa Wang - has played a key role in uncovering a new reovirus that can cause a respiratory tract illness in humans. In this video, Dr Wang explains the significance of the discovery to CSIRO Communication Advisor, Ms Emma Wilkins. (6:00)
The Australian e-Health Research Centre (AEHRC) is the largest national research facility applying information and communication technologies (ICT) to improving health services and clinical treatment for all Australians.
Dr Wang is the architect and main developer of HCA-Vision, CSIRO's automated image analysis software package that rapidly and reproducibly measures functional features of neuronal cells in two-dimensional (2D) images.
CSIRO can provide assistance with optimisation, scale-up, production and purification of recombinant proteins in large quantities: from hundreds of milligrams to kilograms. (2 pages)
The Commonwealth Scientific and Industrial Research Organisation is Australia's national science agency and one of the largest and most diverse research agencies in the world.